Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Depreciation and Depletion: 2014-2024

Historic Depreciation and Depletion for Editas Medicine (EDIT) over the last 11 years, with Dec 2024 value amounting to $5.8 million.

  • Editas Medicine's Depreciation and Depletion fell 54.91% to $721,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 1.30%. This contributed to the annual value of $5.8 million for FY2024, which is 4.77% down from last year.
  • As of FY2024, Editas Medicine's Depreciation and Depletion stood at $5.8 million, which was down 4.77% from $6.1 million recorded in FY2023.
  • Editas Medicine's Depreciation and Depletion's 5-year high stood at $6.3 million during FY2022, with a 5-year trough of $4.0 million in FY2020.
  • Its 3-year average for Depreciation and Depletion is $6.1 million, with a median of $6.1 million in 2023.
  • Per our database at Business Quant, Editas Medicine's Depreciation and Depletion soared by 41.34% in 2020 and then fell by 4.77% in 2024.
  • Over the past 5 years, Editas Medicine's Depreciation and Depletion (Yearly) stood at $4.0 million in 2020, then rose by 27.50% to $5.1 million in 2021, then grew by 24.25% to $6.3 million in 2022, then declined by 3.74% to $6.1 million in 2023, then declined by 4.77% to $5.8 million in 2024.